Ophthalmology Devices Global Market - Forecast to 2021

Publishing Date : September, 2015
Report Code : HCMD 0116
Price:
Single license $4,500
Site license $6,300
Global license $9,000


Note: The report would be dispatched after confirmation of payment

Ophthalmology is a segment of medical science associated with study of anatomy, physiology, diseases of human eye, and developing various therapeutic methods to treat eye diseases. Some of the major eye diseases are either age-related or caused due to chronic disorders. They include various degenerative eye diseases like macular degeneration, cataract, ocular hypertension (glaucoma), and refractive errors among others. Revolution in the field of medical science has led to the rapid development of ophthalmology devices that are invented to effectively treat ocular defects and disorders.

Ophthalmology devices market is segmented on the basis of products type as diagnostic devices, surgical devices and vision care. Based on the applications the ophthalmology devices market is segmented into cataract, glaucoma, age-related macular degeneration, diabetes retinopathy and others (refractive errors, amblyopia, and strabismus). End-users are segmented into hospitals, academic and research laboratories, and others (private eye clinic and vision care outlets).

The global ophthalmology devices market is expected to grow at a mid range single digit CAGR. The global Ophthalmology devices market is expected to reach $42.0 billion by 2021. Increasing incidence of degenerative diseases of eyes, increasing baby boomer population, increase in R&D activities in ophthalmology key players and extensive use of high-end technologies involving use of software and computer aided devices and platforms in ophthalmology drives the market of ophthalmology devices market. Lack of ophthalmologists, economic slowdown and saturation of the market in developed countries are the factors hampering the market growth. 

Lifestyle changes owing to increase in ocular cancer, diabetes and macular degeneration patients, early diagnosis and treatment of diseases, advancement of technology with its wide application areas shows that ophthalmology devices market has vast opportunities in the coming years.

North America accounts for the highest market share followed by Europe. Steep rise in ageing population, increase in minimally invasive surgeries and favourable government policies makes U.S. the leader of ophthalmology devices market. However, Asian countries especially India and China’s are the fast growing regions with its growing demand for ophthalmology devices and increasing research investments.

Major players in ophthalmology devices market include Abbott Medical Optics, Inc. (U.S.), Alcon Laboratories, Inc. (U.S.), Bausch & Lomb, Inc.  (U.S.), Carl Zeiss (Germany), Essilor International SA (U.S.), Haag-Streit Holding AG (Switzerland), Hoya Corporation (Japan), Nidek Co. Ltd (Japan), STAAR Surgicals (U.S.) and Topcon Corporation (Japan).

The report provides an in depth market analysis of the above mentioned segments across the following regions:

  • North America
  • Europe
  • Asia-Pacific 
  • Rest of the World (RoW)
  • 1  Executive summary
  • 2  Introduction
    • 2.1  Key Take-Aways
    • 2.2  Report Description
    • 2.3  Markets Covered
    • 2.4  Stakeholders
    • 2.5  Research Methodology
      • 2.5.1  Market Size Estimation
      • 2.5.2  Market Breakdown & Data Trangulation
      • 2.5.3  Secondary Sources
      • 2.5.4  Key Data Points from Secondary Sources
      • 2.5.5  Primary Sources
      • 2.5.6  Key Data Points from Primary Sources
      • 2.5.7  Assumptions
  • 3  Market Analysis
    • 3.1  Introduction
    • 3.2  Market Segmentation
    • 3.3  Factors influencing market
      • 3.3.1  Drivers & Opportunities
        • 3.3.1.1   Increasing baby boomer population and incidence of degenerative diseases of eyes
        • 3.3.1.2  Increase in R&D activities by ophthalmology key players
        • 3.3.1.3  Extensive use of high-end technologies involving use of software and computer aided devices and platforms
        • 3.3.1.4  Untapped emerging markets
        • 3.3.1.5  Development of minimal invasive surgery
      • 3.3.2  Restraints
        • 3.3.2.1  Lack of ophthalmologists
        • 3.3.2.2  Economic slowdown and saturation of the market in developed countries
        • 3.3.2.3  Reimbursement cuts
      • 3.3.3  Threats
        • 3.3.3.1  Intensified competition
      • 3.3.4  Challenges
        • 3.3.4.1  Lack of insurance coverage in developing countries and insufficient coverage for IOLs in developed countries
        • 3.3.4.2  Extended timelines of device approval
    • 3.4  Regulatory affairs
      • 3.4.1  U.S.
      • 3.4.2  Europe
      • 3.4.3  China
      • 3.4.4  India
      • 3.4.5  Japan
    • 3.5  Reimbursement Scenario
      • 3.5.1  Reimbursement table
    • 3.6  Patent trends
    • 3.7  Technology advancements
    • 3.8  Upcoming technologies
    • 3.9  Porter's Five Force Analysis
      • 3.9.1  Threat of new entrants
      • 3.9.2  Threat of substitutes
      • 3.9.3  Rivalry among existing competitors
      • 3.9.4  Bargaining power of suppliers
      • 3.9.5  Bargaining power of buyers
    • 3.10  Market share analysis by major players
  • 4  Global Ophthalmology devices market, by products
    • 4.1  Introduction
      • 4.1.1  Global ophthalmology diagnostic devices by product types
        • 4.1.1.1  Autorefractors
        • 4.1.1.2  Slit lamp
        • 4.1.1.3  Tonometer
        • 4.1.1.4  Ophthalmoscope
        • 4.1.1.5  Keratometer
        • 4.1.1.6  Corneal topographer
        • 4.1.1.7  Optical coherence tomography
        • 4.1.1.8  Fundus camera
          • 4.1.1.8.1  Non-mydriatic fundus cameras
          • 4.1.1.8.2  Mydriatic fundus cameras
          • 4.1.1.8.3  Hybrid fundus cameras
          • 4.1.1.8.4  Retinopathy of prematurity (ROP)
        • 4.1.1.9  Ophthalmic ultrasound imaging system
        • 4.1.1.10  Retinoscope
        • 4.1.1.11  Perimeter
        • 4.1.1.12  Pachymeter
        • 4.1.1.13  Others
          • 4.1.1.13.1  Snellen chart
          • 4.1.1.13.2  Amsler grid eye test
          • 4.1.1.13.3  Wavefront aberrometer
          • 4.1.1.13.4  Point of care devices
      • 4.1.2  Global ophthalmic surgical devices market
        • 4.1.2.1  Introduction
        • 4.1.2.2  Cataract surgery devices
          • 4.1.2.2.1  Intraocular lens (IOL)
          • 4.1.2.2.2  Phacoemulsification
          • 4.1.2.2.3  OVDS (Ophthalmic Viscosurgical Devices)
          • 4.1.2.2.4  YAG laser
        • 4.1.2.3  Glaucoma surgery devices
          • 4.1.2.3.1  Glaucoma lasers
          • 4.1.2.3.2  Glaucoma surgery
          • 4.1.2.3.3  Glaucoma implants
          • 4.1.2.3.4  Glaucoma systems
        • 4.1.2.4  Refractive error surgical devices
          • 4.1.2.4.1  Photorefractive keratectomy (PRK)
          • 4.1.2.4.2  Laser assisted sub-epithelium keratomileusis (LASEK)
          • 4.1.2.4.3  Laser assisted insitu keratomileusis (LASIK)
          • 4.1.2.4.4  Femtosecond laser
          • 4.1.2.4.5  Epi-LASIK
          • 4.1.2.4.6  Phakic intraocular lens (PIOLs)
        • 4.1.2.5  Vitreoretinal surgical devices
          • 4.1.2.5.1  Vitrectomy
          • 4.1.2.5.2  Photocoagulation
          • 4.1.2.5.3  Illumination
      • 4.1.3  Global vision care devices
        • 4.1.3.1  Introduction
        • 4.1.3.2  Spectacle lenses
        • 4.1.3.3  Contact lenses
  • 5  Ophthalmology devices global market, by applications
    • 5.1  Introduction
    • 5.2  Cataract
    • 5.3  Glaucoma
    • 5.4  Age related macular degeneration
    • 5.5  Diabetic retinopathy (DR)
    • 5.6  Others (Refractive errors, amblyopia, strabismus)
  • 6  Ophthalmology devices global market, by end-users
    • 6.1  Introduction
    • 6.2  Hospitals
    • 6.3  Academic & Research laboratories
    • 6.4  Others
  • 7  Regional Market Analysis
    • 7.1  Introduction
    • 7.2  North America
      • 7.2.1  U.S.
      • 7.2.2  Canada
    • 7.3  Europe
    • 7.4  Asia Pacific
    • 7.5  Rest of the World
  • 8  Company developments
    • 8.1  Introduction
    • 8.2  New product launches
    • 8.3  Agreements, partnerships, collaborations & joint ventures
    • 8.4  Approvals
    • 8.5  Mergers & acquisitions
  • 9  Major companies
    • 9.1  Abbott Laboratories
      • 9.1.1  Overview
      • 9.1.2  Financials
      • 9.1.3  Product Portfolio
      • 9.1.4  Key Developments
      • 9.1.5  Business Strategy
      • 9.1.6  SWOT Analysis
    • 9.2  Carl Zeiss AG
      • 9.2.1  Overview
      • 9.2.2  Financials
      • 9.2.3  Product Portfolio
      • 9.2.4  Key Developments
      • 9.2.5  Business Strategy
      • 9.2.6  SWOT Analysis
    • 9.3  Essilor International
      • 9.3.1  Overview
      • 9.3.2  Financials
      • 9.3.3  Product Portfolio
      • 9.3.4  Key Developments
      • 9.3.5  Business Strategy
      • 9.3.6  SWOT Analysis
    • 9.4  Haag-Streit holdings AG
      • 9.4.1  Overview
      • 9.4.2  Financials
      • 9.4.3  Product Portfolio
      • 9.4.4  Key Developments
      • 9.4.5  Business Strategy
      • 9.4.6  SWOT Analysis
    • 9.5  Hoya corporation
      • 9.5.1  Overview
      • 9.5.2  Financials
      • 9.5.3  Product Portfolio
      • 9.5.4  Key Developments
      • 9.5.5  Business Strategy
      • 9.5.6  SWOT Analysis
    • 9.6  Johnson & Johnson
      • 9.6.1  Overview
      • 9.6.2  Financials
      • 9.6.3  Product Portfolio
      • 9.6.4  Key Developments
      • 9.6.5  Business Strategy
      • 9.6.6  SWOT Analysis
    • 9.7  Nidek Co., Ltd
      • 9.7.1  Overview
      • 9.7.2  Financials
      • 9.7.3  Product Portfolio
      • 9.7.4  Key Developments
      • 9.7.5  Business Strategy
      • 9.7.6  SWOT Analysis
    • 9.8  Novartis AG
      • 9.8.1  Overview
      • 9.8.2  Financials
      • 9.8.3  Product Portfolio
      • 9.8.4  Key Developments
      • 9.8.5  Business Strategy
      • 9.8.6  SWOT Analysis
    • 9.9  STAAR surgical company
      • 9.9.1  Overview
      • 9.9.2  Financials
      • 9.9.3  Product Portfolio
      • 9.9.4  Key Developments
      • 9.9.5  Business Strategy
      • 9.9.6  SWOT Analysis
    • 9.10  Topcon corporation
      • 9.10.1  Overview
      • 9.10.2  Financials
      • 9.10.3  Product Portfolio
      • 9.10.4  Key Developments
      • 9.10.5  Business Strategy
      • 9.10.6  SWOT Analysis
    • 9.11  Valeant pharmaceuticals International Inc
      • 9.11.1  Overview
      • 9.11.2  Financials
      • 9.11.3  Product Portfolio
      • 9.11.4  Key Developments
      • 9.11.5  Business Strategy
      • 9.11.6  SWOT Analysis

        • LIST OF TABLES

        TABLE 1
        Ophthalmology devices global market revenue, by region, (2013-2021) ($MN)
        TABLE 2
        Ophthalmology devices global market revenue, by product type, (2013-2021) ($MN)
        TABLE 3
        Ophthalmology devices global market revenue, by applications, (2013-2021) ($MN)
        TABLE 4
        Ophthalmology devices global market revenue, by end-users, (2013-2021) ($MN)
        TABLE 5
        Ophthalmology devices global market revenue, by product type, (2013-2021) ($MN)
        TABLE 6
        Diagnostic devices global market revenue, by type, (2013-2021) ($MN)
        TABLE 7
        Autorefractometer global market revenue, by region, (2013-2021) ($MN)
        TABLE 8
        Slit lamp global market revenue, by region, (2013-2021) ($MN)
        TABLE 9
        Tonometers global market revenue, by region, (2013-2021) ($MN)
        TABLE 10
        Ophthalmoscope global market revenue, by region, (2013-2021) ($MN)
        TABLE 11
        Keratometer global market revenue, by region, (2013-2021) ($MN)
        TABLE 12
        Corneal topographer global market revenue, by region, (2013-2021) ($MN)
        TABLE 13
        Optical coherence tomography global market revenue, by region, (2013-2021) ($MN)
        TABLE 14
        Fundus camera global market revenue, by region, (2013-2021) ($MN)
        TABLE 15
        Fundus camera global market revenue, by type, (2013-2021) ($MN)
        TABLE 16
        Non-mydriatic fundus camera global market revenue, by region, (2013-2021) ($MN)
        TABLE 17
        Mydriatic fundus camera global market revenue, by region, (2013-2021) ($MN)
        TABLE 18
        Hybrid fundus camera global market revenue, by region, (2013-2021) ($MN)
        TABLE 19
        Retinopathy of prematurity global market revenue, by region, (2013-2021) ($MN)
        TABLE 20
        Ophthalmic ultrasound Imaging system global market revenue, by region, (2013-2021) ($MN)
        TABLE 21
        Retinoscope global market revenue, by region, (2013-2021) ($MN)
        TABLE 22
        Perimeter global market revenue, by region, (2013-2021) ($MN)
        TABLE 23
        Pachymeter global market revenue, by region, (2013-2021) ($MN)
        TABLE 24
        Others (Diagnostics) global market revenue, by region, (2013-2021) ($MN)
        TABLE 25
        Surgical devices global market revenue, by region, (2013-2021) ($MN)
        TABLE 26
        Surgical devices global market revenue, by type, (2013-2021) ($MN)
        TABLE 27
        Cataract surgical devices global market revenue, by type, (2013-2021) ($MN)
        TABLE 28
        Cataract surgery devices global market revenue, by region, (2013-2021) ($MN)
        TABLE 29
        IOL global market revenue, by region, (2013-2021) ($MN)
        TABLE 30
        Phacoemulsification global market revenue, by region, (2013-2021) ($MN)
        TABLE 31
        OVD global market revenue, by region, (2013-2021) ($MN)
        TABLE 32
        Glaucoma surgery devices global market revenue, by region, (2013-2021) ($MN)
        TABLE 33
        Refractive surgery devices global market revenue, by region, (2013-2021) ($MN)
        TABLE 34
        Vitreoretinal surgery devices global market revenue, by region, (2013-2021) ($MN)
        TABLE 35
        Vision care global market revenue, by region, (2013-2021) ($MN)
        TABLE 36
        Vision care global market revenue, by type, (2013-2021) ($MN)
        TABLE 37
        Spectacle lenses global market revenue, by region, (2013-2021) ($MN)
        TABLE 38
        Contact lenses global market revenue, by region, (2013-2021) ($MN)
        TABLE 39
        Ophthalmology devices global market revenue, by application, (2013-2021) ($MN)
        TABLE 40
        Cataract global market revenue, by region, (2013-2021) ($MN)
        TABLE 41
        Glaucoma global market revenue, by region, (2013-2021) ($MN)
        TABLE 42
        Age related macular degeneration market revenue, by region, (2013-2021) ($MN)
        TABLE 43
        Diabetic retinopathy global market revenue, by region, (2013-2021) ($MN)
        TABLE 44
        Others (applications) global market revenue, by region, (2013-2021) ($MN)
        TABLE 45
        Ophthalmology devices global market revenue, by end-users, (2013-2021) ($MN)
        TABLE 46
        Hospitals global market revenue, by region, (2013-2021) ($MN)
        TABLE 47
        Academics & research laboratories global market revenue, by region, (2013-2021) ($MN)
        TABLE 48
        Other end users global market revenue, by region, (2013-2021) ($MN)
        TABLE 49
        North American ophthalmology devices market revenue, by product type, (2013-2021) ($MN)
        TABLE 50
        North American diagnostic devices market revenue, by type, (2013-2021) ($MN)
        TABLE 51
        North American fundus cameras market revenue, by type, (2013-2021) ($MN)
        TABLE 52
        North American surgical devices market revenue, by type, (2013-2021) ($MN)
        TABLE 53
        North American cataract surgery devices market revenue, by type, (2013-2021) ($MN)
        TABLE 54
        North American vision care market revenue, by type, (2013-2021) ($MN)
        TABLE 55
        North American ophthalmology devices market revenue, by application, (2013-2021) ($MN)
        TABLE 56
        North American ophthalmology devices market revenue, by end-user, (2013-2021) ($MN)
        TABLE 57
        European ophthalmology devices market revenue, by type, (2013-2021) ($MN)
        TABLE 58
        European diagnostic devices market revenue, by type, (2013-2021) ($MN)
        TABLE 59
        European fundus cameras market revenue, by type, (2013-2021) ($MN)
        TABLE 60
        European surgical devices market revenue, by type, (2013-2021) ($MN)
        TABLE 61
        European cataract surgery devices market revenue, by type, (2013-2021) ($MN)
        TABLE 62
        European vision care market revenue, by type, (2013-2021) ($MN)
        TABLE 63
        European ophthalmology devices market revenue, by application, (2013-2021) ($MN)
        TABLE 64
        European ophthalmology devices market revenue, by end-users, (2013-2021) ($MN)
        TABLE 65
        Asia-pacific ophthalmology devices market revenue, by type, (2013-2021) ($MN)
        TABLE 66
        Asia-pacific diagnostic devices market revenue, by type, (2013-2021) ($MN)
        TABLE 67
        Asia-pacific fundus cameras market revenue, by type, (2013-2021) ($MN)
        TABLE 68
        Asia-pacific surgical devices market revenue, by type, (2013-2021) ($MN)
        TABLE 69
        Asia-pacific cataract surgery devices market revenue, by type, (2013-2021) ($MN)
        TABLE 70
        Asia-pacific vision care market revenue, by type, (2013-2021) ($MN)
        TABLE 71
        Asia-pacific ophthalmology devices market revenue, by application, (2013-2021) ($MN)
        TABLE 72
        Asia-pacific ophthalmology devices market revenue, by end-users, (2013-2021) ($MN)
        TABLE 73
        RoW ophthalmology devices market revenue, by type, (2013-2021) ($MN)
        TABLE 74
        RoW diagnostics devices market revenue, by types, (2013-2021) ($MN)
        TABLE 75
        RoW fundus cameras market revenue, by type, (2013-2021) ($MN)
        TABLE 76
        RoW surgical devices market revenue, by type, (2013-2021) ($MN)
        TABLE 77
        RoW cataract surgery devices market revenue, by type, (2013-2021) ($MN)
        TABLE 78
        RoW vision care market revenue, by type, (2013-2021) ($MN)
        TABLE 79
        RoW ophthalmology devices market revenue, by application, (2013-2021) ($MN)
        TABLE 80
        RoW ophthalmology devices market revenue, by end-users, (2013-2021) ($MN)
        TABLE 81
        New product launches (2013-2015)
        TABLE 82
        Agreements, partnership, collaboration & joint ventures (2013-2015)
        TABLE 83
        Approvals (2013-2015)
        TABLE 84
        Mergers & acquisitions (2013-2015)
        TABLE 85
        Abbott laboratories: total revenue and R&D expenses, (2012-2014) ($MN)
        TABLE 86
        Abbott laboratories: total revenue, by segments, (2012-2014) ($MN)
        TABLE 87
        Abbott laboratories: revenue segments of medical devices, (2013-2014)($MN)
        TABLE 88
        Abbott laboratories: total revenue, by geography, (2012-2014) ($MN)
        TABLE 89
        Carl Zeiss AG: total sales and R&D expenses (2012-2014) ($MN)
        TABLE 90
        Carl Zeiss: total sales, by segments, (2012-2014) ($MN)
        TABLE 91
        Carl Zeiss: total sales, by geography, (2012-2014) ($MN)
        TABLE 92
        Essilor: total revenue and R&D expenses, (2012-2014) ($MN)
        TABLE 93
        Essilor international: total revenue, by segments, (2012-2014) ($MN)
        TABLE 94
        Essilor international: total revenue, by geography, (2012-2014) ($MN)
        TABLE 95
        Hoya corporation: total revenue and R&D expenses (2012-2014) ($MN)
        TABLE 96
        Hoya corporation: total revenue, by segments, (2012-2014) ($MN)
        TABLE 97
        Hoya corporation: total revenue, by geography, (2012-2014) ($MN)
        TABLE 98
        Johnson & Johnson: total revenue and R&D expenses (2012-2014) ($MN)
        TABLE 99
        Johnson & Johnson: total revenue, by segments, (2012-2014) ($MN)
        TABLE 100
        Johnson & Johnson: total revenue, by geography, (2012-2014) ($MN)
        TABLE 101
        Novartis: total revenue and R&D expenses, (2012-2014) ($MN)
        TABLE 102
        Novartis AG: total revenue, by segments, (2012-2014) ($MN)
        TABLE 103
        Novartis AG: segmental revenue of Alcon laboratories, (2012-2014) ($MN)
        TABLE 104
        Novartis AG: total revenue, by geography, (2012-2014) ($MN)
        TABLE 105
        Staar surgical company: total revenue and R&D expenses, (2012-2014) ($MN)
        TABLE 106
        Staar surgical company: total revenue, by segments, (2012-2014) ($MN)
        TABLE 107
        Staar surgical company: total revenue, by geography (2012-2014) ($MN)
        TABLE 108
        Topcon Corporation.: total sales and R&D expenses (2012-2014) ($MN)
        TABLE 109
        Topcon corporation: total sales, by segments, (2012-2014) ($MN)
        TABLE 110
        Topcon corporation: total sales, by geography, (2012-2014) ($MN)
        TABLE 111
        Valeant pharmaceutical international, inc: total revenue and R&D expenses, (2012-2014) ($MN)
        TABLE 112
        Valeant pharmaceutical international, inc: total revenue, by segments, (2012-2014) ($MN)
        TABLE 113
        Valeant pharmaceutical international, inc: total revenue, by geography, (2012-2014) ($MN)

        LIST OF FIGURES

        FIGURE 1
        Global ophthalmology devices market share and revenue, by region (2013-2021)
        FIGURE 2
        Research methodology: ophthalmology devices global market
        FIGURE 3
        Ophthalmology devices market: top-down and bottom-up approach
        FIGURE 4
        Ophthalmology devices market: forecasting model
        FIGURE 5
        Ophthalmology devices market: market breakdown & data triangulation
        FIGURE 6
        Ophthalmology devices market segmentation
        FIGURE 7
        Market dynamics
        FIGURE 8
        Ophthalmology devices market: patent filing by major players (2010-2015)
        FIGURE 9
        Ophthalmology devices market: patent filing by segment, (2010-2015)
        FIGURE 10
        Ophthalmology devices market: porter's analysis
        FIGURE 11
        Ophthalmology devices global market share analysis, by key players, 2014
        FIGURE 12
        Ophthalmology devices global market revenue, by type, (2014 v's 2021) ($MN)
        FIGURE 13
        Global ophthalmology device market revenue, by surgery (2014 v's 2021) ($MN)
        FIGURE 14
        Ophthalmology devices global market revenue, by application (2014 v's 2021) ($MN)
        FIGURE 15
        Ophthalmology devices global market revenue, by end users (2013 v's 2021) ($MN)
        FIGURE 16
        Global ophthalmology devices market revenue, by region (2013-2021) ($MN)
        FIGURE 17
        North American ophthalmology devices market size, by product type, application & end-user outlook, (2014 v's 2021)
        FIGURE 18
        European ophthalmology market size, by product type, application & end-user outlook, (2014 v's 2021)
        FIGURE 19
        Asia-pacific Ophthalmology devices market size, by type, product, application & end-user outlook, (2014 v's 2021)
        FIGURE 20
        Row ophthalmology devices market size, by type, product, application & end-user outlook, (2014 v's 2021)
        FIGURE 21
        Key growth strategies, (2013-2015)
        FIGURE 22
        SWOT: Abbott laboratories
        FIGURE 23
        SWOT: Carl Zeiss
        FIGURE 24
        SWOT: Essilor international
        FIGURE 25
        SWOT: Haag-Streit AG
        FIGURE 26
        SWOT: Hoya Corporation
        FIGURE 27
        SWOT: Johnson & Johnson
        FIGURE 28
        SWOT: Novartis AG
        FIGURE 29
        SWOT: STAAR surgical company
        FIGURE 30
        SWOT: Topcon Corporation
        FIGURE 31
        SWOT: Valeant Pharmaceuticals International